PacificHealth Laboratories Inc

PacificHealth Laboratories Inc. Stock Analysis PHLI

United States Consumer Staples Nano Cap
PacificHealth Laboratories, founded in 1996 by two prominent scientists, started with a singular purpose – to help athletes achieve their personal goals. The company is headquartered in Parsippany, New Jersey and currently employs 8 full-time employees. The firm collaborates with various nutritionists, biochemists and sports scientists. Its product categories include endurance, recovery, thrive and wellness. Its product collections include Accelerade 4:1, Endurox R4 4:1, Endurox Excel, Gummies, Nutragize, Accel Gel's 4:1, and 2nd Surge. Accelerade is a sports drink that contains protein in a patented 4:1 carbohydrate-protein ratio. Endurox R4, with its patented 4:1 carb-protein ratio is focused on muscle recovery. The firm's products include Endurox Excel, Healthy Joints, Daily Wellness, Anti-inflammatory, Ashwagandha, Immuno ARMOR, TurboTest, Adreno+, Mushroom X, P2Biotics, EstroCell, Accel Gel, 2nd Surge, water bottle and Nutrient Timing.
Read More

PacificHealth Laboratories Inc (PHLI) Chart

Key Statistics of PacificHealth Laboratories Inc (PHLI)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$0.00$0.00

Today's Open

$0.00

Volume

-

P/E Ratio (TTM)

-

52 Week Range

$0.00$0.01

Market Cap

-

Avg. Volume

-

Dividend Yield

-

Financial Metrics & Statements of PacificHealth Laboratories Inc (PHLI)

FAQ's for PacificHealth Laboratories Inc (PHLI)

  • According to Musaffa’s Shariah screening methodology, PacificHealth Laboratories Inc (PHLI) is currently classified as NOT COVERED as of March 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Disclaimer

The content provided on this website is intended solely for informational and educational purposes. Musaffa is a technology, data, education, and research company. We are not licensed financial service provider by the authorized relevant financial service regulator in India or any other regulatory government body, and we do not offer or facilitate any trading, brokerage, investment, or financial advisory services. We do not deliberately target an audience seeking financial services.

By accessing this website, you acknowledge and confirm that you are seeking information relating to Musaffa of your own accord, and that there has been no form of solicitation, advertisement, or inducement by Musaffa or its members. Musaffa shall not be liable for the consequences of any action taken by relying on the material or information provided on this website. The contents of this website are the intellectual property of Musaffa.